Login to Your Account


Bioxcel plans $69M IPO for AI-identified candidates

By Michael Fitzhugh
Staff Writer

Wednesday, February 14, 2018

Bioxcel Therapeutics Inc., a company using artificial intelligence to repurpose existing compounds for new uses, has filed to raise up to $69 million in an initial public offering intended to help it advance two candidates through proof of concept (POC), and possibly further.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription